Discover 1,134 paid clinical trials in Bridgeport, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,134
Featured
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
for
Alzheimers Disease
Location: New Haven CT, The Bronx NY, Laurelton NY, New York NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07177352
Phase 3, Recruiting
Featured
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Stamford CT, Morristown NJ, Philadelphia PA, Nashua NH,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase 3, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Westbury NY, The Bronx NY, Hartford CT,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06793215
Phase 3, Recruiting
Featured
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: Lake Success NY, Hartford CT, New York NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 2 - 17
Code: NCT07158242
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Bridgeport CT, Stamford CT, Danbury CT, The Bronx NY,
Location: Bridgeport CT, Stony Brook NY, New York NY, Brooklyn NY,
Sponsor: ReCor Medical, Inc.
Sex: All
Age: 18+
Code: NCT06297291
Recruiting
Active & Responsive
Project STRONGER: Stepped Care for Opioid Use Disorder Treatment Engagement and Recovery
for
Opioid Use Disorder, Intimate Partner Violence (IPV),
Location: Bridgeport CT, West Haven CT
Sponsor: Yale University
Sex: Female
Age: 18+
Code: NCT07115030
Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Driving Simulator Training For Adults With Acquired Brain Injuries
for
Acquired Brain Injury
Location: Fairfield CT
Sponsor: Sacred Heart University
Sex: All
Age: 18+
Code: NCT07378592
Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Fairfield CT, Trumbull CT, Derby CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase 3, Recruiting
Active & Responsive
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
for
Advanced Esophageal Adenocarcinoma,
Location: Fairfield CT, Trumbull CT, Derby CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06203600
Phase 2, Phase 3, Recruiting
Active & Responsive
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
for
Plasma Cell Myeloma
Location: Fairfield CT, Trumbull CT, Derby CT, New Haven CT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT05561387
Phase 3, Recruiting
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: Fairfield CT, Trumbull CT, Derby CT, New Haven CT,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 60+
Code: NCT06377852
Phase 3, Recruiting
Active & Responsive
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
for
HER2-positive Metastatic Breast Cancer
Location: Fairfield CT, Trumbull CT, Derby CT, New Haven CT,
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT06551116
Recruiting
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Trumbull CT, New Haven CT, Stony Brook NY, The Bronx NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase 2, Recruiting
Active & Responsive
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Trumbull CT, New Haven CT, North Haven CT, New York NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06287775
Phase 1, Phase 2, Recruiting
Active & Responsive
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
for
Depression
Location: Milford CT, New Haven CT, Atlanta GA, Nashville TN,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT06713616
Phase 3, Recruiting
Active & Responsive
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
for
Hypertension
Location: Bridgeport CT, New York NY, Neptune City NJ, Camden NJ,
Sponsor: SoniVie Inc.
Sex: All
Age: 22 - 70+
Code: NCT06559891
Recruiting
Active & Responsive
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
for
Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV,